T43.292D Poisoning by other antidepressants, intentional self-harm, subsequent encounter

Name of the Condition

• Poisoning by other antidepressants, intentional self-harm, subsequent encounter
• Technical term: T43.292D

Summary

This code represents intentional self-harm poisoning by antidepressant medications not classified under more specific subcategories, during a subsequent encounter. It applies when exposure is deliberate, typically due to suicidal intent, and the patient is receiving ongoing care related to this event after the initial treatment phase. The condition is identified based on clinical presentation, medication history, and the nature of the exposure.

Causes

Intentional self-harm poisoning may result from deliberate overdose of antidepressants, often driven by suicidal ideation or intent. This excludes accidental exposure, adverse effects, or underdosing scenarios.

Risk Factors

• History of mental health disorders, such as depression or anxiety, increasing self-harm risk.
• Prior suicide attempts or suicidal ideation.
• Access to antidepressant medications.
• Social isolation or lack of support systems.
• Acute stressors or crises.

Symptoms

• Drowsiness, confusion, or altered mental status.
• Nausea, vomiting, or abdominal pain.
• Rapid heart rate, irregular heartbeat, or blood pressure changes.
• Seizures, tremors, or muscle spasms.
• Respiratory depression or failure.
• Coma or loss of consciousness.

Diagnosis

Diagnosis is based on clinical evaluation, including assessment of mental status, physical examination, and medication history. Laboratory tests may confirm antidepressant levels, and imaging or other studies may rule out complications. Documentation must specify intentional self-harm and the subsequent encounter context.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing underlying mental health needs. This may include activated charcoal, supportive care, psychiatric evaluation, and follow-up mental health services. Interventions are tailored to the severity of poisoning and the patient’s clinical status.

Prognosis and Follow-Up

Prognosis depends on the extent of poisoning, timeliness of treatment, and access to mental health support. Subsequent encounters require ongoing monitoring for recurrence, adherence to treatment plans, and coordination with mental health providers. Follow-up ensures resolution of acute symptoms and addresses long-term risk reduction.

Complications

Potential complications include organ damage (e.g., liver or kidney), cardiac arrhythmias, respiratory failure, or neurological deficits. Severe cases may result in permanent disability or death. Psychological complications, such as persistent suicidal ideation, may also occur.

Lifestyle & Prevention

Prevention strategies include secure storage of medications, adherence to prescribed dosing, and regular mental health check-ins. Building support systems, avoiding substance misuse, and seeking help during crises can reduce risk. Education on medication safety and recognizing warning signs of self-harm is critical.

When to Seek Professional Help

Seek immediate care for symptoms of poisoning, such as altered mental status, seizures, or difficulty breathing. Ongoing professional help is necessary for mental health support, especially if suicidal thoughts or behaviors persist. Regular follow-up with healthcare providers is recommended to monitor recovery and prevent recurrence.

Tips for Medical Coders

Document the intent (intentional self-harm) and encounter type (subsequent) clearly. Ensure the antidepressant is classified as "other" (not a more specific subtype). Verify that the encounter follows the initial treatment phase and is not for acute stabilization. Code T43.292D is appropriate when the patient is receiving ongoing care for the self-harm event.